Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

NCT05174169 is registered in ClinicalTrials.gov with NRG Oncology as lead sponsor.

NCT NCT05174169
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05174169 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Lead sponsor
NRG Oncology
Phase
Phase 2/3
Overall status
Recruiting
Start date
July 8, 2022
Completion date
March 10, 2030
Enrollment
1,912 (estimated)
Sites
1,077

Conditions

As the registry lists them; a condition with its own page is linked.

stage iii colon cancer